Fast, flexible, cost‑effective development and manufacturing of monoclonal, bispecific and multivalent antibodies for biopharmaceutical companies using a continuous bioprocessing platform to deliver mg–kg scale and enable personalized medicine. One‑stop CDMO services covering cell‑line and USP/DSP development, analytical/formulation work, quality/validation, project management, regulatory, tech transfer to GMP and clinical research.